Across TCGA pan-cancer cohorts, C9orf152 mass-spec protein differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of C9orf152’s most consistent transcriptional readouts.
The strongest signal is observed in lung adenocarcinoma (LUAD), where C9orf152 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types C9orf152 is over-expressed in tumor.
LUAD are the cancer types where C9orf152 tumor–normal differential expression is most reproducible.